Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hongyan Sheng
Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction Between Efavirenz and Antituberculosis Drug Therapy Through Mechanism-Based Inactivation of CYP2A6
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug-Induced Hepatitis
Hepatology
Medicine
Hepatology
Metabolism of (+)-Fenchone by CYP2A6 and CYP2B6 in Human Liver Microsomes
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism Between Memantine and Cimetidine
Pharmaceutics
Pharmaceutical Science
CYP2B6 *6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers
Journal of Clinical Pharmacology
Pharmacology
CYP 2B6 Genotype‐dependent Inhibition of CYP 1A2 and Induction of CYP 2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Metabolism of the Antituberculosis Drug Ethionamide
Current Drug Metabolism
Clinical Biochemistry
Pharmacology
Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
‘Covering the Tail’ After Stopping Efavirenz-Based Antiretroviral Therapy
Southern African Journal of HIV Medicine
Infectious Diseases
Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium Tuberculosis Isolates in Thailand
Infection and Drug Resistance
Infectious Diseases
Pharmacology
